Gaurav Pandey

Employment

• Guru Gobind Singh Indraprastha University Professor
  2023 - Present
• International Vaccine Institute Head of Vaccine Process Development
  2022 - 2024
• Guru Gobind Singh Indraprastha University Associate Professor
  2016 - 2023
• Malaria Vaccine Development Program Associate Director
  2009 - 2016
• Panacea Biotec (India) Deputy Manager: Upstream Process
  2007 - 2009
• Jawaharlal Nehru University Research Associate
  2006 - 2007
• Osaka University Research student
  2002 - 2006

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (17)

• High Cell Density Fermentation Strategy for High-Level Soluble Expression of Glucagon-like Peptide-1 Analogue in Escherichia coli
  Fermentation 2026 DOI: 10.3390/fermentation12010053
  +Save
• An effective strategy for soluble bovine enterokinase expression in Escherichia coli
  Biotechnology Letters 2025 DOI: 10.1007/s10529-025-03655-8
  +Save
• Development of invasive non-typhoidal Salmonella conjugate vaccines and their evaluation in a trivalent formulation with typhoid conjugate vaccine
  Vaccine 2025 DOI: 10.1016/j.vaccine.2025.126913
  +Save
• Improved Stability and Manufacturability of Nucleocapsid Antigens for SARS-CoV2 Diagnostics through Protein Engineering
  Biomolecules 2023 DOI: 10.3390/biom13101524
  +Save
• Staphylococcal Protein A with Engineered Cysteine: Comparison of Monomeric Content as a Critical Quality Attribute during Intracellular and Extracellular Expression
  Fermentation 2022 DOI: 10.3390/fermentation8040150
  +Save
• Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial
  npj Vaccines 2018 DOI: 10.1038/s41541-018-0083-3
  +Save
• Production of recombinant PvDBPII, receptor binding domain of Plasmodium vivax Duffy binding protein, and evaluation of immunogenicity to identify an adjuvant formulation for vaccine development
  Protein Expression and Purification 2017 DOI: 10.1016/j.pep.2015.06.011
  +Save
• Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175 (vol 10, e0117820, 2015)
  Plos One 2015 DOI: 10.1371/journal.pone.0137816
  +Save
• Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175
  Plos One 2015 DOI: 10.1371/journal.pone.0117820
  +Save
• Kinetic studies of recombinant human interferon-gamma expression in continuous cultures of E. coli
  Journal of Industrial Microbiology & Biotechnology 2009 DOI: 10.1007/s10295-009-0632-x
  +Save